These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3406814)

  • 21. Platelet activating factor in stool from patients with ulcerative colitis and Crohn's disease.
    Hocke M; Richter L; Bosseckert H; Eitner K
    Hepatogastroenterology; 1999; 46(28):2333-7. PubMed ID: 10521992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Saliva Interleukin-6 in patients with inflammatory bowel disease.
    Aleksandra Nielsen A; Nederby Nielsen J; Schmedes A; Brandslund I; Hey H
    Scand J Gastroenterol; 2005 Dec; 40(12):1444-8. PubMed ID: 16316893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on the metabolic significance of digestion and absorption. 2. Correlation between albumin metabolism and digestion-absorption disorders in protein losing enteropathis].
    Mizuno Y; Iwasaki M; Kajiyama Y; Isozaki M; Sawada K
    Nihon Rinsho; 1967 May; 25(5):966-79. PubMed ID: 5625216
    [No Abstract]   [Full Text] [Related]  

  • 24. Protein-losing enteropathies in malignancy.
    Waldmann TA; Broder S; Strober W
    Ann N Y Acad Sci; 1974; 230():306-17. PubMed ID: 4595947
    [No Abstract]   [Full Text] [Related]  

  • 25. Gastroenteric clearance of albumin in liver icrrhosis; relative protein-losing gastroenteropathy.
    Takada A; Kobayashi K; Takeuchi J
    Digestion; 1970; 3(3):154-64. PubMed ID: 5449663
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on the metabolic significance of digestive absorption. (1). Relationship between albumin metabolism in protein-losing enteropathies and digestive absorption disorders].
    Mizuno Y
    Nihon Rinsho; 1967 Apr; 25(4):794-9 contd. PubMed ID: 4863153
    [No Abstract]   [Full Text] [Related]  

  • 28. Crohn's disease but not chronic ulcerative colitis induces the expression of PAI-1 in enteric neurons.
    Laerum OD; Illemann M; Skarstein A; Helgeland L; Ovrebø K; Danø K; Nielsen BS
    Am J Gastroenterol; 2008 Sep; 103(9):2350-8. PubMed ID: 18844621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indications for albumin treatment in chronic cardiac insufficiency.
    Grabowski R
    Pol Med J; 1966; 5(4):815-20. PubMed ID: 5964902
    [No Abstract]   [Full Text] [Related]  

  • 30. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
    Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
    Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S100A12: a noninvasive marker of inflammation in inflammatory bowel disease.
    van de Logt F; Day AS
    J Dig Dis; 2013 Feb; 14(2):62-7. PubMed ID: 23146044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal protein loss in rheumatoid arthritis, studied with 51Cr-chromic chloride and 125I albumin.
    Plantin LO; Strandberg O
    Scand J Rheumatol; 1974; 3(4):169-73. PubMed ID: 4617300
    [No Abstract]   [Full Text] [Related]  

  • 33. Exudation of Cr 51 albumin into the lumen of the digestive tract.
    Skála I; Vesely KT; Petrus P
    Rev Roum Med Intern; 1972; 9(2):201-3. PubMed ID: 4538508
    [No Abstract]   [Full Text] [Related]  

  • 34. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core.
    Hanski C; Born M; Foss HD; Marowski B; Mansmann U; Arastéh K; Bachler B; Papenfuss M; Niedobitek F
    J Pathol; 1999 Jul; 188(3):304-11. PubMed ID: 10419600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inflammatory intestinal diseases and parenteral feeding].
    Rasslan S; Rolim EG; Pacheco Júnior AM; Taddeo EF; Mandia Neto J; Fava J
    Rev Paul Med; 1982; 99(1):3-6. PubMed ID: 6815765
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunolocalization and expression of kinin B1R and B2R receptors in human inflammatory bowel disease.
    Stadnicki A; Pastucha E; Nowaczyk G; Mazurek U; Plewka D; Machnik G; Wilczok T; Colman RW
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G361-6. PubMed ID: 15805101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal protein loss in Crohn's disease.
    Beeken WL; Busch HJ; Sylwester DL
    Gastroenterology; 1972 Feb; 62(2):207-15. PubMed ID: 4637981
    [No Abstract]   [Full Text] [Related]  

  • 39. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
    Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
    J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of diarrhea in inflammatory bowel diseases.
    Binder HJ
    Ann N Y Acad Sci; 2009 May; 1165():285-93. PubMed ID: 19538318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.